Durvalumab is currently approved for a number of cancer types. Though not approved in gastric cancer, the MATTERHORN regimen ...
Adding Imfinzi (durvalumab) to Bacillus Calmette-Guérin (BCG) therapy helped patients with high-risk, non-muscle invasive ...
Zach Cregger's critically acclaimed horror movie Weapons is $28 on 4K Blu-ray, but if you want the Steelbook Edition, it's ...
Victoria, British Columbia, Canada, October 17, 2025. Teuton Resources Corp. (“Teuton” or “the Company”) (“TUO”-TSX-V) ("TFE" ...
Injuries to starting tackles Rashawn Slater and Joe Alt have prompted the Los Angeles Chargers to seek reinforcements.
Gun Song, last out winner of the local Grade 2 Beldame, worked in company Thursday over the Belmont Park dirt training track ...
However, in addition to quarterback Brock Purdy, tight end George Kittle, receiver Ricky Pearsall and linebacker Fred Warner ...
The furthest intersection returns 49m at 6.1% CuEq1 and remains open at depth; These results will form part of the Mineral Resource Estimate update set for this quarter ...
Atezolizumab shows no significant benefit over BCG alone in treating high-risk non-muscle invasive bladder cancer, according to the ALBAN trial results.
The Pensacola News Journal is working with high schools in Escambia and Santa Rosa County to put their top students in the ...
In TNBC, pembrolizumab at a tenth of the current standard dose, plus chemotherapy, increased pCR compared to chemotherapy alone.
Durvalumab addition to BCG therapy significantly improved DFS in BCG-naive, high-risk NMIBC patients, achieving a 32% reduction in DFS event risk. The combination therapy was well-tolerated, with ...